Since in ALK+ ALCL, the JAK/STAT pathway is a crucial signaling mediator activated by oncogenic NPM-ALK, we investigated whether NPM-ALK regulated CD45 expression. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.